The combination effect of Korean red ginseng saponins with kanamycin and cefotaxime against methicillin-resistant Staphylococcus aureus

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 8, 2008, Pages 1614-1617

  Sung, Woo Sang ^a   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Antibacterial activity; Combination effect; Ginsenoside; Korean red ginseng; Methicillin resistant staphylococcus aureus

Indexed keywords

CALCEIN; CEFOTAXIME; GINSENOSIDE; KANAMYCIN; LIPOSOME; SAPONIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DRUG POTENTIATION; GINSENG; KOREAN RED GINSENG; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VIBRIO VULNIFICUS;

ANTI-BACTERIAL AGENTS; CEFOTAXIME; DRUG COMBINATIONS; FLUORESCEINS; GINSENOSIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; KANAMYCIN; KINETICS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PANAX; STAPHYLOCOCCUS AUREUS;

EID: 48849091417     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1614     Document Type: Article

References (23)

1. Ge Y., Difuntorum S., Touami S., Critchley I., Burli R., Jiang V., Drazan K., Moser H., Antimicrob. Agents Chemother., 46, 3168-3174 (2002).
2. De Pasquale A., J. Ethnopharmacol., 11, 1-16 (1984).
3. Dixon R. A., Nature (London), 411, 843-847 (2001).
4. Rates S. M. K., Toxicon, 39, 603-613 (2001).
5. Liu W. K., Xu S. X., Che C. T., Life Sci., 67, 1297-1306 (2000).
6. Yun T. K., Yun Y. S., Han I. W., Cancer Detect. Prev., 6, 515-525 (1983).
7. Kim J. Y., Germolec D. R., Luster M. I., Immunopharmacol. Immunotoxicol., 12, 257-276 (1990).
8. Kim T. H., Lee Y. S., Cho C. K., Park S., Choi S. Y., Yool S. Y., Cancer Biother. Radiopharm., 11, 267-272 (1996).
9. Sung W. S., Lee D. G., Biol. Pharm. Bull., 31, 139-142 (2008).
10. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing, fifteenth informational supplement, approved standard MS100-S15," CLSI, Wayne, PA, 2005.
11. Sung W. S., Lee I.-S., Lee D. G., J. Microbiol. Biotechnol., 17, 1797-1804 (2007).
12. Cavalieri S. J., Biehle J. R., Sanders Jr., W. E., Antimicrob. Agents Chemother., 39, 1542-1545 (1995).
13. Kobayashi Y., Uchida H., Kawakami Y., J. Antimicrob. Chemother., 30, 871-872 (1992).
14. Cha D. S., Chinnan M. S., Crit. Rev. Food Sci. Nutr., 44, 223-237 (2004).
15. Mattick A. T. R., Hirsch A., Nature (London), 154, 551 (1944).
16. Ruhr E., Sahl H.-G., Antimicrob. Agents Chemother., 27, 841-845 (1985).
17. Lohner K., Latal A., Degovics G., Garidel P., Chem. Phys. Lipids, 111, 177-192 (2001).
18. Lee S.-A., Kim Y. K., Lim S. S., Zhu W. L., Ko H., Shin S. Y., Hahm K.-S., Kim Y., Biochemistry, 46, 3653-3663 (2007).
19. Martini N. D., Katerere D. R. P., Eloff J. N., J. Ethnopharmacol., 93, 207-212 (2004).
20. Francis G., Kerem Z., Makkar H. P. S., Becker K., Br. J. Nutr., 88, 587-605 (2002).
21. Mirelman D., Nuchamowitz Y., Antimicrob. Agents Chemother., 17, 115-119 (1980).
22. Misumi M., Nishimura T., Komai T., Tanaka N., Biochem. Biophys. Res. Commun., 84, 358-365 (1978).
23. Yamada T., Nagata A., Ono Y., Suzuki Y., Yamanouchi T., Antimicrob. Agents Chemother., 27, 921-924 (1985).